Physician profile
Peter Sungjin Pak
NPI 1588955694
$5,234.92
in general payments reported to CMS, 2019-2025
8 companies · $81.93 in 2025
The $81.93 reported for 2025 was less than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.00 · 2022: $22.94 · 2023: $174 · 2024: $4,932 · 2025: $81.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $1,015 · Travel and Lodging: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $1,015.14 |
| Travel and Lodging | $172.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,701.37 | 2024-2025 | |
| Medtronic, INC. | $173.97 | 2023 | Signia |
| Davol INC. | $162.71 | 2024 | Arista Ah Flexitip |
| Aroa Biosurgery Incorporated | $110.50 | 2024-2025 | |
| Ethicon US, LLC | $24.00 | 2021 | |
| Janssen Pharmaceuticals, INC | $22.94 | 2022 | |
| Haemonetics Corporation | $22.77 | 2025 | Teg6s Hemostasis System |
| Solventum Corporation | $16.66 | 2025 | V.A.C. Veraflo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Pak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.